A Study to Evaluate ALN-6222 in Participants With Obesity
Clinical trial NCT07624071 · RECRUITING
Trial details
- NCT number
- NCT07624071
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-04
- Primary completion
- 2027-12-14
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.